Avantax Planning Partners, Inc. Omeros Corp Transaction History
Avantax Planning Partners, Inc.
- $3.45 Billion
- Q3 2025
A detailed history of Avantax Planning Partners, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 10,100 shares of OMER stock, worth $74,841. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,100
Previous 10,100
-0.0%
Holding current value
$74,841
Previous $30,000
36.67%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OMER
# of Institutions
153Shares Held
35.1MCall Options Held
2.2MPut Options Held
2.72M-
Ingalls & Snyder LLC New York, NY4.11MShares$30.4 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$30.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$29.7 Million0.0% of portfolio
-
Ubs Group Ag2.22MShares$16.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.99MShares$14.7 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $465M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...